Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis
Authors:
Abstract
No abstract availableKeywords
Funding Information
- China National Natural Science Foundation (81373219)
- Scientific Research of The First Hospital of China Medical University (fsfh1007)
- Higher Education Department of Liaoning Province Research (L2010604, L2010613)
This publication has 19 references indexed in Scilit:
- Clinical significance of serum decoy receptor 3 levels in patients with systemic sclerosisEuropean Journal Of Dermatology, 2012
- TL1A and DR3, a TNF family ligand‐receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammationImmunological Reviews, 2011
- Upregulation and nuclear localization of TNF‐like Cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesionsExperimental Dermatology, 2011
- Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancerBiochemical Pharmacology, 2011
- Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferationThe FASEB Journal, 2010
- Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosusClinical and Experimental Immunology, 2008
- Soluble TNF-Like Cytokine (TL1A) Production by Immune Complexes Stimulated Monocytes in Rheumatoid ArthritisThe Journal of Immunology, 2007
- Cytokines in the pathogenesis of rheumatoid arthritisNature Reviews Immunology, 2007
- LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicingProceedings of the National Academy of Sciences, 1997
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988